Method of Participation
Participants should readthe activity information, review the activity in its entirety, and complete the online post-test and evaluation. Upon completing this activity as designed and achieving a passing score on the post-test, you will be directed to a Web page that will allow you to receive your certificate of credit via e-mail or you may print it out at that time.The online post-test and evaluation can be accessed at https://tinyurl.com/FluDigital18.
Inquiries about CME accreditation may be directed to the Postgraduate Institute for Medicine (PIM) at www.pimed.com or (303) 799-1930.
Activity questions may be directed to Global Academy for Medical Education at email@example.com or 973-290-8225.
Joint Provider Statement
In support of improving patient care, this activity has been planned and implemented by Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Christopher P. Chao, MD
Joseph D. Toscano, MD
Cameron R. Wolfe, MBBS, MPH
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Dr Chao reports nothing to disclose.
Dr Toscano discloses that he is a member of the speakers bureau for Reckitt Benckiser.
Prof Wolfe discloses that he is a member of the drug safety monitoring boards for Ansun, GlaxoSmithKline, Janssen, and Visterra.
Planners and Managers
The PIM planners and managers have nothing to disclose. The Global Academy for Medical Education planners and managers have nothing to disclose
The 2017-2018 influenza season in the United States was the deadliest in 4 decades, resulting in at least 80,000 deaths. Factors contributing to the problem include lower-than-optimal vaccination rates, especially among vulnerable populations (children and older adults); the relative lack of efficacy (~36%) of the available vaccines; and the emergence of resistance to antiviral treatments. At the peak of the season, flu accounted for more than 7% of all outpatient visits to emergency departments and urgent care centers. Clinicians who practice in an urgent care setting are on the frontlines of influenza prevention and treatment. These providers would benefit from education that illustrates best practices for managing influenza in a timely and efficient manner. Guidance is needed about strategies for preventing flu outbreaks in the household and the community, appropriate use of antiviral therapies, and awareness of current and emerging drugs that could significantly affect the approach to managing influenza in the urgent care setting.
At the conclusion of this program, participants should be better able to:
- Recognize the impact of the 2017-2018 influenza season on the delivery of urgent care
- Review the mechanisms of action of available and emerging influenza treatments and determine their roles in therapy for appropriately selected patients
- Design optimal strategies for preventing and treating influenza infection in the urgent care setting
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Activity Viewing Requirements
Supported Browsers: Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets: Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.
Copyright © 2018 by Global Academy for Medical Education, LLC; and its Licensors. All rights reserved. No part of this publication may be reproduced or transmitted in any form, by any means, without prior written permission of the Publisher. Global Academy for Medical Education, LLC, will not assume responsibility for damages, loss, or claims of any kind arising from or related to the information contained in this publication, including any claims related to the products, drugs, or services mentioned herein.